检索

期
标题
作者
卷 95, 编号 2 (2023)
Irritable bowel syndrome phenotypes: leading factors of genetics and epigenetics, mechanisms of formation
Gaus O., Livzan M.
PDF
(Rus)
卷 96, 编号 2 (2024)
Risk factors for irritable bowel syndrome: A review
Gaus O., Livzan M., Gavrilenko D.
PDF
(Rus)
卷 95, 编号 2 (2023)
The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion
Baulo E., Belostotsky N., Akhmadullina O., Dbar S., Bykova S., Parfenov A.
PDF
(Rus)
卷 95, 编号 2 (2023)
The course and clinical manifestations of Peutz–Jeghers syndrome in the Russian population
Savelyeva Т., Ponomarenko А., Shelygin Y., Kuzminov А., Vyshegorodtsev D., Loginova А., Pikunov D., Goncharova Е., Likutov А., Mainovskaya О., Tsukanov А.
PDF
(Rus)
卷 95, 编号 1 (2023)
Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study
Maev I., Okhlobystina O., Khalif I., Andreev D.
PDF
(Rus)
卷 95, 编号 12 (2023)
Long-term consequences of COVID-19 in patients with functional bowel disorders, rehabilitation prospective of microbiocenosis-oriented therapy
Patsenko M., Ardatskaya M., Anuchkin A., Butorova L., Gaivoronsky I., Nugaeva N., Levin V., Pavlov A., Topchiy T., Tuaeva E.
PDF
(Rus)
卷 96, 编号 4 (2024)
Features of the effect of a probiotic, containing Lactobacillus and Bifidobacterium on the intestinal microbiota and clinical symptoms of irritable bowel syndrome
Khalaidzheva K., Nikitina N., Astrashkova O., Drozdov V., Melkonyan G., Shikh E.
PDF
(Rus)
卷 94, 编号 9 (2022)
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria
Andreev D., Bordin D., Vyuchnova E., Lebedeva E., Dicheva D., Umyarova R., Maev I.
PDF
(Rus)
卷 94, 编号 2 (2022)
The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study
Yakovenko E., Strokova T., Ivanov A., Iakovenko A., Gioeva I., Aldiyarova M.
PDF
(Rus)
卷 95, 编号 8 (2023)
Long-term probiotic administration for irritable bowel syndrome: a legal need
Solovyeva O., Nekrasova A., Topalova I., Ponomarenko V., Tsurtsumiia D., Ilyashevich I.
PDF
(Rus)
卷 81, 编号 2 (2009)
Postinfection irritable bowel syndrome
Papfenov A., Puchkina I., Ataullakhanov P., Belaya O., Chikunova B., Pichugin A., Kozhemyakina E., Parfenov A., Ruchkina I., Ataullakhanov R., Belaya O., Chikunova B., Pichugin A., Kozhemyakina E.
卷 88, 编号 2 (2016)
Irritable bowel syndrome in the light of Rome consensus III (2006): 10 years later
Parfenov A., Albulova E., Ruchkina I.
PDF
(Rus)
卷 90, 编号 12 (2018)
Biomarkers of inflammatory bowel disease activity
Fadeeva N., Korneeva I., Knyazev O., Parfenov A.
PDF
(Rus)
卷 90, 编号 2 (2018)
The cardiovascular system in patients with functional and inflammatory bowel diseases
Maev I., Kazulin A., Andreev D.
PDF
(Rus)
卷 93, 编号 8 (2021)
Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study
Andreev D., Maev I.
PDF
(Rus)
卷 89, 编号 4 (2017)
Disaccharidase deficiency and functional bowel diseases
Parfenov A., Akhmadullina O., Sabelnikova E., Belostotsky N., Kirova M., Khomeriki S., Bykova S.
PDF
(Rus)
卷 92, 编号 2 (2020)
Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem
Osadchuk M., Svistunov A., Kireeva N., Osadchuk M.
PDF
(Rus)
卷 92, 编号 2 (2020)
Esophageal disorders in patients with irritable bowel syndrome
Morozova Y., Pogromov A., Mnatsakanyan M., Tashchyan O., Kolosova K.
PDF
(Rus)
卷 87, 编号 2 (2015)
Fecal calprotectin concentration in the differential diagnosis of bowel diseases
Osipenko M., Livzan M., Skalinskaia M., Lialiukova E.
卷 87, 编号 2 (2015)
Small intestinal bacterial overgrowth as a cause of lactase deficiency
Fadeeva N., Ruchkina I., Parfenov A., Shcherbakov P.
卷 79, 编号 4 (2004)
Efficacy of the Rome criteria II in diagnosis of irritable bowel syndrome
Parfenov A., Ruchkina I., Orobei Y., Bykova S.
卷 87, 编号 2 (2015)
Pharmacotherapy for irritable bowel syndrome in the context of evidence-based medicine
Maev I., Cheremushkin S., Kucheriavyĭ I., Cheremushkina N.
卷 93, 编号 8 (2021)
The role of visceral hypersensitivity in the pathogenesis of irritable bowel syndrome
Makarova A., Ruchkina I., Parfenov A., Indeykina L., Romashkina N.
PDF
(Rus)
卷 85, 编号 8 (2013)
Irritable bowel syndrome: The present view of the problem
Maev I., Cheremushkin S., Sutugina E., Cheremushkina N.
卷 84, 编号 8 (2012)
Pathogenetic treatment for chronic constipation
Parfenov A.
卷 92, 编号 8 (2020)
Diet therapy for irritable bowel syndrome
Bakulin I., Avalueva E., Оrеshkо L., Sitkin S., Shevyakov M., Serkova M., Semenova E.
PDF
(Rus)
卷 88, 编号 8 (2016)
Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
Tsukanov V., Rzhavicheva O., Vasjutin A., Dunaevskaja O., Tonkih J., Bronnikova E.
PDF
(Rus)
卷 81, 编号 2 (2009)
Gastrointestinal symptoms in adult population of Novosibirsk city: prevalence and risk factors
Peshetnikov O., Kupilovich S., Bobak M., Malyutina S., Pylenkova E., Reshetnikov O., Kurilovich S., Bobak M., Malyutina S., Pylenkova E.
卷 92, 编号 2 (2020)
Multidisciplinary treatment of the patient with a severe irritable bowel syndrome
Ruchkina I., Vyaznikova A., Indeykina L., Degterev D., Parfenov A.
PDF
(Rus)
卷 87, 编号 8 (2015)
The development of functional gastrointestinal diseases: Genetic aspects
Akhmedov V.
卷 81, 编号 2 (2009)
Development of theory on intestinal dysfunction in the XXI century
Papfenov A., Parfenov A.
1 - 31 的 31 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##